Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
35.06%
↑ 232% vs avg
Percentile
P83
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-26.59%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 35.06% |
| Q2 2025 | -23.40% |
| Q1 2025 | 12.96% |
| Q4 2024 | -30.65% |
| Q3 2024 | -27.84% |
| Q2 2024 | 5.83% |
| Q1 2024 | 31.33% |
| Q4 2023 | 6.25% |
| Q3 2023 | -8.84% |
| Q2 2023 | 9.26% |
| Q1 2023 | 55.00% |
| Q4 2022 | -11.11% |
| Q3 2022 | -13.29% |
| Q2 2022 | -368.85% |
| Q1 2022 | 75.40% |
| Q4 2021 | 63.95% |
| Q3 2021 | 82.83% |
| Q2 2021 | 18.66% |
| Q1 2021 | 9.25% |
| Q4 2020 | 11.75% |
| Q3 2020 | -14.89% |
| Q2 2020 | -556.93% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |